ATRC vs OGN · rev $294.9M vs P/E 3.4, rev $3.02B
AtriCure Inc (ATRC) versus Organon & Co (OGN) — a side-by-side from cached financials, not a winner call.
AtriCure Inc (ATRC) is a medical instruments & supplies company listed on US.
Organon & Co (OGN) is a drug manufacturers - general company listed on US.
Latest reported ATRC revenue for 2026-06-30 was $294.9M. Net income was $9.1M. ATRC currently screens at market cap $1.37B.
Latest reported OGN revenue for 2026-06-30 was $3.02B. Net income was $254.0M. OGN currently screens at market cap $2.52B and trailing P/E 3.4.
ATRC currently screens at market cap $1.37B. OGN currently screens at market cap $2.52B and trailing P/E 3.4.
Not investment advice. Open the ATRC and OGN stock pages for the full models.
Not investment advice.